Site-specific labeling of his-tagged nanobodies with 99mTc: A practical guide

Methods in Molecular Biology

Volumn 911, Issue , 2012, Pages 485-490

  Xavier, Catarina ^a   Devoogdt, Nick ^a   Hernot, Sophie ^a   Vaneycken, Ilse ^a   D'Huyvetter, Matthias ^a   De Vos, Jens ^a,b   Massa, Sam ^a,b   Lahoutte, Tony ^a,c   Caveliers, Vicky ^a,c  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Radiochemistry; Site specific labeling

Indexed keywords

HISTIDINE; NANOBODY; TECHNETIUM 99M; TRICARBONYL TC 99; UNCLASSIFIED DRUG; TECHNETIUM;

ARTICLE; BINDING AFFINITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; PRIORITY JOURNAL; RADIOCHEMISTRY; CHEMISTRY; METHODOLOGY;

HISTIDINE; ISOTOPE LABELING; SINGLE-DOMAIN ANTIBODIES; TECHNETIUM;

EID: 84871872770     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-968-6_30     Document Type: Article

References (20)

1. Andros G, Harper PV, Lathrop KA (1965) Pertechnetate-99m localization in man with applications to thyroid scanning and the study of thyroid physiology. J Clin Endocrinol Metab 25:1067-1076
2. Mandalapu BP, Amato M, Stratmann HG (1999) Technetium Tc 99m sestamibi myocar-dial perfusion imaging: current role for evaluation of prognosis. Chest 115:1684-1694
3. 99m Tc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells. Eur J Nucl Med Mol Imaging 38:899-910
4. Schibli R, Schubiger PA (2002) Current use and future potential of organometallic radiop-harmaceuticals. Eur J Nucl Med Mol Imaging 29:1529-1542
5. +. J Am Chem Soc 123: 3135-3136
6. 99m Tc-aquaion labels peptide to an unprecedented high specific activity. J Nucl Med 40: 1913-1917
7. Waibel R et al (1999) Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 17:897-901
8. Du J et al (2001) Technetium-99m labelling of glycosylated somatostatin-14. Appl Radiat Isot 55:181-187
9. Willuda J et al (1999) High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res 59:5758-5767
10. Zahnd C et al (2010) efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size. Cancer Res 70:1595-1605
11. Orlova A et al (2006) Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 af fibody for single-photon imaging of HER2 expression in tumors. J Nucl Med 47:512-519
12. Hamers-Casterman C et al (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446-448
13. Vincke C et al (2009) General strategy to humanize a camelid single-domain antibody and identi fication of a universal humanized nano-body scaffold. J Biol Chem 284:3273-3284
14. Dumoulin M et al (2002) Single-domain antibody fragments with high conformational stability. Protein Sci 11:500-515
15. Tchouate Gainkam LO et al (2011) Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice. Contrast Media Mol Imaging 6:85-92
16. Vaneycken I et al (2011) Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer. FASEB J 25: 2433-2446
17. Vaneycken I et al (2011) Immuno-imaging using nanobodies. Curr Opin Biotechnol 22:877-881
18. Tchouate Gainkam LO et al (2011) Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy. Mol Imaging Biol 13: 940-948
19. Vaneycken I et al (2010) In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT. J Nucl Med 51:1099-1106
20. De Groeve K et al (2010) Nanobodies as tools for in vivo imaging of specific immune cell types. J Nucl Med 51:782-789